Navigation Links
Global Fund Increases AIDS, Tuberculosis and Malaria Prevention and Treatment Measures by 30-50% Over One Year
Date:7/8/2009

WASHINGTON, July 8 /PRNewswire-USNewswire/ -- Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.3 million people on treatment for HIV/AIDS, 5.4 million people have been treated for tuberculosis, and 88 million insecticide-treated nets have been distributed to prevent malaria infection. In addition, more than 500,000 HIV-positive pregnant women have been treated to prevent their babies from being born with HIV. Over the past year, the number of people accessing ARVs through Global Fund-financed programs has increased by 31%, the number given tuberculosis drugs has increased by 38% and the number of nets distributed has increased by 49%.

These latest results strengthen evidence that investments during the past five years have resulted in the most significant progress ever achieved in the global fight against these three diseases. Recent evidence suggests that global mortality from tuberculosis is now declining, AIDS mortality among adults in several high-burden countries in Africa is declining, and malaria elimination efforts have made tremendous progress, with reductions in the number of cases and malaria-related child mortality falling between 50% and 80% in a growing number of countries.(1) The Global Fund has been a leader in this progress, contributing nearly 25% of global financing for HIV/AIDS and almost two-thirds of the financing for tuberculosis and malaria.

"These impressive results from Global Fund-financed programs are a testament to what the world can do together to fight disease and improve health around the world," said Natasha Bilimoria, Executive Director of Friends of the Global Fight. "Because of strong U.S. leadership and support, the Global Fund is able to partner with countries around the world, improving not only citizens' health but in turn strengthening local and national economies. It's a development tool that continues to be a sound investment and shows real results."

Together, AIDS, tuberculosis and malaria kill about six million people per year. With grants worth $16 billion in 140 countries around the world, the Global Fund has become the world's leading global public health financier.

"In less than eight years, the Global Fund has gone from a concept to a driver of change," said Michel Kazatchkine, Executive Director of the Global Fund. "When we first began our work in 2002, few people in developing countries were being treated for AIDS or tuberculosis. Malaria was a neglected disease. Many countries simply did not have the resources to fight these diseases effectively. Now the story is changing dramatically. There is still much to be done, but we are making real progress and I am proud that the Global Fund is a leader in this global effort."

In 2002, the U.S. government made the founding $200 million pledge to the Global Fund. In FY2009, the U.S. government appropriated $1 billion for the Global Fund, the highest amount contributed to date. Strong support from the U.S. government is a critical component of Global Fund success; every $1 committed by the U.S. is leveraged to generate $2 in contributions from other donors.

"We are at an historic moment in the fight for better health," Bilimoria said. "With Global Fund financing, health and health systems are improving dramatically around the world."

For further details about the Global Fund's prevention and treatment numbers, please see: http://www.theglobalfund.org/en/pressreleases/.

FRIENDS OF THE GLOBAL FIGHT AGAINST AIDS, TUBERCULOSIS AND MALARIA

Friends of the Global Fight works to educate, engage and mobilize American decision makers to support the Global Fund to Fight AIDS, Tuberculosis and Malaria and the fight to end the worldwide burden of these three diseases. For more information about Friends of the Global Fight, visit www.TheGlobalFight.org.

THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA

The Global Fund is a unique global public/private partnership dedicated to attracting and disbursing additional resources to prevent and treat HIV/AIDS, tuberculosis and malaria. This partnership between governments, civil society, the private sector and affected communities represents a new approach to international health financing. The Global Fund works in close collaboration with other bilateral and multilateral organizations to supplement existing efforts dealing with the three diseases.

(1) The Global Fund, "Scaling Up for Impact: Results Report," March 2009. Online at http://www.theglobalfund.org/documents/publications/progressreports/ProgressReport2008_en.pdf.


'/>"/>
SOURCE Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... February 06, 2016 , ... Research ... treatment helps to reduce the frequency and level of relapse. , ... Healthy Identity and Purpose,” will explore the critical tasks of the recovery phase ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment and retention ... and scientific initiatives have all marked the last 12 months at Roswell Park ... of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined the many ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... Pass, OR (PRWEB) , ... February 05, 2016 , ... ... with modern technology, such water may be safer than regular municipal or well water. ... advocate and radio host Sharon Kleyne, could go a long way toward increasing public ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... announced the election of Patrick McDermott as Chairman of the National Board of Directors. ... Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA President ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... ALBANY, New York , February 5, 2016 /PRNewswire/ ... A new Transparency Market Research report states that the ... bn in 2014 and is predicted to reach US$185.9 ... a CAGR of 6.50% from 2014 to 2020. The ... Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by ...
(Date:2/5/2016)... England , February 5, 2016 ... --> Today, VoicePower Ltd - The Speech Recognition People, announced ... been deployed to improve patient care, reduce turnaround times and to ... Wirral CCG ,- VoicePower client since 2013 Challenge: ... Challenge: --> - Six doctors ,- Wirral CCG ...
(Date:2/4/2016)... 4, 2016  The Senior Care Pharmacy Coalition ... Committee Chairman Jason Chaffetz (R-UT) and ... hearing , "Developments in the Prescription Drug ... growing questions about abusive pharmacy benefit manager (PBM) ... and Ranking Member Elijah Cummings (D-MD) are diligent, ...
Breaking Medicine Technology: